e.g. Filippa Pettersson or Cancer Res. 75(6) , 1102-12, (2015) or 10.1002/anie.201600521
Substituted 4-hydroxyphenyl sulfonamides as pathway-selective estrogen receptor ligands
…, MA Ashwell, E Trybulski, MM O'Donnell…
Index: Sabatucci, Joseph P.; Ashwell, Mark A.; Trybulski, Eugene; O'Donnell, Mary-Margaret; Moore, William J.; Harnish, Douglas C.; Chadwick, Christopher C. Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 4 p. 854 - 858
The transcription factor nuclear factor-κB (NF-κB) is a key component in the onset of inflammation. We describe here a series of 4-hydroxyphenyl sulfonamide estrogen receptor (ER) ligands that selectively inhibit NK-κB transcriptional activity but are devoid of conventional estrogenic activity.